← Back to Search

Peer Support for Inflammatory Bowel Disease Distress

N/A
Recruiting
Research Sponsored by Jennifer Jones
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult IBD patient (18 years or older)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 8
Awards & highlights

Study Summary

This trial will study IBD Strong Peer, an evidence-based, peer-led intervention to help people with IBD-related psychological distress. It will provide implementation & effectiveness data to improve & adapt the intervention to local needs.

Who is the study for?
This trial is for adults over 18 with Inflammatory Bowel Disease (IBD) who are newly diagnosed, switching from child to adult care, experiencing a flare-up or medication change, recently hospitalized, or preparing for surgery. It's not suitable for those outside these criteria.Check my eligibility
What is being tested?
The IBD Strong Peer2Peer program is being tested against a waitlist control group. This peer-led virtual support aims to help manage psychological distress in adults with IBD. The study will gather data on how well it works and how it can be improved.See study design
What are the potential side effects?
Since this intervention involves peer-to-peer support rather than medication, traditional side effects aren't expected. However, participants may experience emotional discomfort when discussing personal health challenges.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older with inflammatory bowel disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence rate
Attrition rate
Fidelity
+10 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Waitlist -controlsExperimental Treatment1 Intervention
Group II: IBD Strong Peer2Peer interventionExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Jennifer JonesLead Sponsor
2 Previous Clinical Trials
682 Total Patients Enrolled
Crohn's and Colitis CanadaOTHER
7 Previous Clinical Trials
1,187 Total Patients Enrolled
Nova Scotia Health AuthorityOTHER
258 Previous Clinical Trials
83,734 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the projected enrollment for this clinical investigation?

"Affirmative. The information on clinicialtrials.gov confirms this medical trial is searching for participants and was initially published on June 1st, 2023; the data was last refreshed on November 24th, 2023. 120 individuals are required to participate at one clinical site."

Answered by AI

Is the current study still seeking volunteers?

"Per clinicaltrials.gov, the study is actively recruiting patients and was declared open on June 1st 2023 with its last update taking place November 24th of that same year."

Answered by AI

Does this clinical research extend to senior individuals aged 75 or above?

"As per the inclusion criteria, suitable candidates for this study must be aged 18 to 99. Separately, 138 trials are available for minors and 421 studies are open to participants over 65 years of age."

Answered by AI

What qualifications are necessary to partake in this medical trial?

"Participants aged 18 to 99 with Crohn's disease can apply for this clinical trial. A total of 120 volunteers are sought after to partake in the experiment."

Answered by AI
~65 spots leftby Apr 2025